KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.3.

  • Pfizer's Debt Ratio fell 427.72% to 0.3 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3, marking a year-over-year decrease of 427.72%. This contributed to the annual value of 0.3 for FY2024, which is 538.58% down from last year.
  • Per Pfizer's latest filing, its Debt Ratio stood at 0.3 for Q3 2025, which was down 427.72% from 0.3 recorded in Q2 2025.
  • Pfizer's Debt Ratio's 5-year high stood at 0.89 during Q4 2022, with a 5-year trough of 0.18 in Q4 2022.
  • Over the past 5 years, Pfizer's median Debt Ratio value was 0.3 (recorded in 2023), while the average stood at 0.33.
  • Examining YoY changes over the last 5 years, Pfizer's Debt Ratio showed a top increase of 7486.07% in 2023 and a maximum decrease of 6681.95% in 2023.
  • Over the past 5 years, Pfizer's Debt Ratio (Quarter) stood at 0.21 in 2021, then dropped by 13.94% to 0.18 in 2022, then soared by 74.86% to 0.32 in 2023, then dropped by 5.39% to 0.3 in 2024, then decreased by 2.08% to 0.3 in 2025.
  • Its Debt Ratio was 0.3 in Q3 2025, compared to 0.3 in Q2 2025 and 0.3 in Q1 2025.